ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.

Biotechnology

Health Care

Therapeutics

ImCheck Therapeutics

Pierre d'Epenoux

Sophie Agaugué

Katrien Lemmens

Tracey Butler

Patrick BRUNE

Nabila Z.

Hans Henrik Chrois Christensen

Florence ALCARAZ

Emmanuel VALENTIN

Diane Delpy-Sampson

Claude Knopf

Carla Cano

Alem Truneh

The Research and Development Team at ImCheck Therapeutics is dedicated to advancing the discovery and optimization of immuno-modulatory antibodies aimed at treating various cancers. This multidisciplinary team collaborates on preclinical research, conducts extensive testing to evaluate antibody efficacy, and leads innovative strategies to bring new therapies from concept to clinical trial. By leveraging expertise in cytometry, program management, and oncology, they drive the development pipeline and ensure the successful transition of promising therapies into clinical settings.

Research and Development Team

Leadership Team

Finance and Administration Team

Research and Development Team

About

Team members

Other teams at ImCheck Therapeutics

Leadership Team

Finance and Administration Team